INE406M01024
INE406M01024
ERIS LIFESCIENCES LIMITED
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 31.148.900.000 | 28.792.600.000 | 8.2% |
| Cost of Revenue | 8.182.000.000 | 7.301.000.000 | 12.1% |
| Gross Profit | 22.966.900.000 | 21.491.600.000 | 6.9% |
| 14.553.800.000 | 14.458.600.000 | 0.7% | |
| Operating Income | 8.413.100.000 | 7.033.000.000 | 19.6% |
| Pretax Income | 6.385.400.000 | 4.888.700.000 | 30.6% |
| Net Income Common Stockholders | 6.195.200.000 | 3.518.400.000 | 76.1% |
| -- | -- | -- | |
| -- | -- | -- |